MLSS News & Events

The company said, "As we enter 2026, we expect to transition from a period of stabilization to a more offensive posture, investing selectively in initiatives that accelerate growth while maintaining financial discipline. In January, we launched our dental ambassador program nationally, with plans to expand the model to CompuFlo over time, and in February, we launched our CompuFlo advisor program with more than ten physician partners and dedicated reimbursement support infrastructure. We expect these efforts, along with continued strength in our dental business and expansion into new international markets to begin contributing to revenue growth over the coming quarters, with more pronounced impact anticipated in the second and third quarters of 2026 as these initiatives gain scale. Our objective is clear: position the Company to achieve cash flow breakeven in early 2027 and create long-term shareholder value."

Eric Hines, CEO of Milestone Scientific commented: "When I joined Milestone in August 2025, we were in the middle of the third quarter following a period without consistent executive leadership. During that time, certain spending had occurred that was not always aligned with revenue generation or disciplined capital allocation. Since August, the Company has taken deliberate steps to strengthen financial discipline across the organization, scrutinizing every expense, prioritizing initiatives tied to revenue and measurable ROI, and eliminating spending that does not directly support our path to sustainable growth. We also made a conscious decision not to raise new capital simply to fund inefficient practices. Instead, our focus has been on responsible stewardship of shareholder capital and building a stronger operational foundation."

Milestone Scientific announced the launch of the CompuFlo Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary to optimize long-term Medicare reimbursement rates. The program, which commenced on February 1, 2026, targets high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor jurisdictions, including Novitas, First Coast, Noridian, and Palmetto. These jurisdictions represent a strategic first phase of execution, with infrastructure designed to support phased expansion across additional MAC regions throughout the United States. By engaging Key Opinion Leaders to generate a targeted 1,000-2,000 case submissions in the initial six-month phase, Milestone is executing a structured clinical and reimbursement roadmap to transition CPT code 0777T from Category III to Category I status, that could enhance commercial adoption and long-term revenue visibility.

Milestone Scientific announced the launch of The Wand Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, education, and adoption of The Wand STA System within the dental market. The program leverages experienced dental professionals to share real-world clinical insights, workflow considerations, and firsthand experiences with colleagues. This peer-driven approach is intended to increase high-quality engagement with prospective practices and encourage direct interaction with Milestone for product demonstrations, training, and deeper evaluation of the clinical and operational benefits of The Wand STA system. The Ambassador Program pilot launched on December 8 with six registered dental professionals in select U.S. markets. Milestone reports early positive feedback from the pilot group and strong inbound interest from additional practitioners seeking to participate, reinforcing management's confidence in the program's scalability and relevance. Milestone plans to expand the program to approximately 250 dental professionals over the next 12 months, supported by a structured onboarding and education framework, centralized learning resources, and defined pathways that connect interested practices with Milestone's commercial and clinical support teams. Internal program tools provide real-time visibility into engagement activity, enabling the company to measure effectiveness, optimize execution, and scale efficiently. Based on early pilot activity and historical performance metrics, Milestone expects the Ambassador Program-combined with an increased focus on new and emerging social media channels-to drive approximately 2-3x growth in product demonstrations, supporting more informed evaluations and contributing to stronger demo-to-sales conversion efficiency over time.